Tokyo Tape
Sign in
← Delta-Fly Pharma

Quarterly report · Q3

4598.TEDINET S100Q8SE
Period2022-04-01 → 2022-12-31
Filed2023-02-14
StandardJapan GAAP
ConsolidatedNo
Data checks8 of 8 passed
Key figures · 31
MetricValuePeriodScopeSource row
Operating income−¥1.0bn2022-04-01 → 2022-12-31StandaloneOperating income
Operating income−¥833m2021-04-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥1.0bn2022-04-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥964m2021-04-01 → 2022-03-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥835m2021-04-01 → 2021-12-31StandaloneOrdinary income
Profit before tax−¥1.0bn2022-04-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥835m2021-04-01 → 2021-12-31StandaloneIncome before income taxes
Net income−¥1.0bn2022-04-01 → 2022-12-31StandaloneProfit loss
Net income−¥967m2021-04-01 → 2022-03-31StandaloneNet income loss (5-year summary)
Net income−¥838m2021-04-01 → 2021-12-31StandaloneProfit loss
Total assets¥953mat 2022-12-31StandaloneAssets
Total assets¥1.3bnat 2022-03-31StandaloneAssets
Total assets¥1.4bnat 2021-12-31StandaloneTotal assets (5-year summary)
Total liabilities¥202mat 2022-12-31StandaloneLiabilities
Total liabilities¥91mat 2022-03-31StandaloneLiabilities
Net assets / equity¥751mat 2022-12-31StandaloneNet assets
Net assets / equity¥1.2bnat 2022-03-31StandaloneNet assets
Net assets / equity¥1.4bnat 2021-12-31StandaloneNet assets (5-year summary)
Cash and deposits¥887mat 2022-12-31StandaloneCash and deposits
Cash and deposits¥1.3bnat 2022-03-31StandaloneCash and deposits
EPS (basic)¥-190.182022-04-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-75.042022-10-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-178.582021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-154.652021-04-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-51.682021-10-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio78.4%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio93.1%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio94.5%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Shares issued6,054,700at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued5,419,600at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued5,419,600at 2021-12-31StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 223
ItemContextValueUnit
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember747537000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember750000JPY
Subscription rights to sharesCurrentQuarterInstant_NonConsolidatedMember3190000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1233161000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember750728000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember1324352000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember952899000JPY
Operating revenues rev oaPrior1YTDDuration_NonConsolidatedMember100000000JPY
Operating revenues rev oaCurrentYTDDuration_NonConsolidatedMember－JPY
Research and development expenses cos exp oaPrior1YTDDuration_NonConsolidatedMember683456000JPY
Research and development expenses cos exp oaCurrentYTDDuration_NonConsolidatedMember794524000JPY
Other selling general and administrative expenses cos exp oaPrior1YTDDuration_NonConsolidatedMember249337000JPY
Other selling general and administrative expenses cos exp oaCurrentYTDDuration_NonConsolidatedMember231845000JPY
Business expenses cos exp oaPrior1YTDDuration_NonConsolidatedMember932793000JPY
Business expenses cos exp oaCurrentYTDDuration_NonConsolidatedMember1026369000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-832793000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-1026369000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember61000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember7000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember120000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember8000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember182000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember15000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember621000JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember6592000JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember1879000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember2950000JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember2500000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember9542000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-835111000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-1035896000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-835111000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-1035896000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember2416000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember2403000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember2416000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember2403000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-837528000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-1038299000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)四国財務局長
Filing date cover pageFilingDateInstant2023-02-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第13期第３四半期(自　2022年10月１日　至　2022年12月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)Ｄｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ　株式会社
Company name in english cover pageFilingDateInstantＤｅｌｔａ－Ｆｌｙ　Ｐｈａｒｍａ，Ｉｎｃ．
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　江島　淸
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)徳島県徳島市川内町宮島錦野37番地の５
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)088-637-1055(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　管理部門担当　黒滝　健一

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 8 of 8 passed
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2022-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass